Literature DB >> 35309115

Genetic Variants of MicroRNA and DROSHA Genes in Association With the Risk of Tuberculosis in the Amazon Population.

Diana Feio da Veiga Borges Leal1, Mayara Natália Santana da Silva2, Lucas Favacho Pastana1, Marianne Rodrigues Fernandes1, Aidalucy do Socorro Costa de Athayde1, Débora Christina Ricardo Fernandes Porchera1, Cleonardo Augusto da Silva1, Antônio André Conde Modesto1, Paulo Pimentel De Assumpcão1, Sidney Emanuel Batista Dos Santos1,2, Ney Pereira Carneiro Dos Santos1.   

Abstract

Tuberculosis (TB) is a chronic infection caused by Mycobacterium tuberculosis (Mtb) with high incidence and mortality. Studies reported that host genetic variants might be associated with the risk of tuberculosis. The aim of this study was to perform an association study between 26 single nucleotide polymorphisms (SNPs) and tuberculosis and evaluate whether these SNPs may confer risk factors to tuberculosis in the Amazon population. There were 52 males and 126 females, with total of 178 healthy controls. Genotyping was performed using TaqMan Open Array Genotyping. Ancestry-informative markers were used to estimate the ancestral proportions of the individuals in the case and control groups. The results indicated that the SNPs rs10035440 (DROSHA), rs7372209 (miR26-a1), rs1834306 (miR100), rs4919510 (miR608), and rs10739971 (pri-let-7a-1) were significantly associated with high risk and rs3746444 (miR499) and rs6505162 (miR423), with low risk of developing tuberculosis in the Amazon population. Our study concluded that seven miRNA polymorphisms were associated with tuberculosis. Our study contributes to a better understanding of TB pathogenesis and may promote the development of new diagnostic tools against M. tuberculosis infection.
Copyright © 2022 Leal, Santana da Silva, Pastana, Fernandes, Athayde, Fernandes Porchera, Silva, Modesto, De Assumpcão, Santos and Santos.

Entities:  

Keywords:  drosha; genetic variants; microRNA; risk factor; tuberculosis

Year:  2022        PMID: 35309115      PMCID: PMC8924412          DOI: 10.3389/fgene.2022.850058

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


1 Introduction

Tuberculosis (TB) is a chronic infection caused by Mycobacterium tuberculosis (Mtb), and it remains one of the most serious infections with high incidence and mortality, mostly in developing countries. According to the World Health Organization (WHO) report, there were an estimated number of 10 million new TB cases and 1.4 million deaths worldwide in 2019 (WHO 2020). Early detection and appropriate treatment are the most important control strategy for TB. However, there is a low rate of TB cases detected and officially notified. In addition, smear microscopy and culture are the “gold standards” for the diagnosis of TB; however, faster and more sensitive diagnostic tests are required to improve diagnosis and patient management during infection (Acharya et al., 2020). Emerging evidence suggests that miRNAs might be involved in the pathogenesis of a variety of human diseases, including TB (Sabir et al., 2018). MicroRNAs are an important regulator of biological processes, such as innate immune response against various infections (Wang and Cui 2012). They regulate the primary function of macrophages, dendritic cells, and natural killer cells (NKCs) and influence other regulation of proteins involved in the innate and adaptive immune pathways (Sahu et al., 2017; Tamgue et al., 2019). Comparative miRNA expression profiles in individuals with active tuberculosis and healthy controls were studied in an Amazon population. Three different miRNA expressions, hsa-miR-4732-5p, hsa-miR-486-3p, and hsa-let-7g-5p, were identified in tuberculosis patients (Silva et al., 2021). However, different miRNA expressions can vary between individual samples during treatment and recovery (Kleinsteuber et al., 2013). Recently, genetic variants in IL10, VDR, and microRNA genes were reported in subsequent studies in different human populations. However, there were few results of the association between these microRNA polymorphisms and tuberculosis susceptibility (Song et al., 2013; Silva et al., 2020). The aim of this study was to perform an association study between SNPs in miRNA and DROSHA and tuberculosis and evaluate whether these selected SNPs may confer susceptibility or protection to TB in the Amazon population.

2 Materials and Methods

2.1 Subjects

There were 52 males and 126 females, with total of 178 healthy controls in the Amazon population. The subjects enrolled in the case group were individuals diagnosed with active TB. The diagnosis of TB was based on clinical, radiological, sputum acid-fast bacillus (AFB) smear positivity, and/or culture. The patients were diagnosed with TB for a minimum of 6 months in Hospital João Barros Barreto in Belém city (Pará, Brazil). The control group was a special group with healthy individuals who were participants from a Geriatric Program in Hospital João Barros Barreto in Belém city (Pará, Brazil), with a high probability to be in contact with TB disease. The study was approved by the Ethical Committee of Universidade Federal do Pará, and all subjects gave written informed consent (protocol number: 42106720.2.0000.5634).

2.2 Single Nucleotide Polymorphism Selection

A total of 26 single nucleotide polymorphisms were selected based on previous reports of the marker in associative studies found in the Pubmed (www.ncbi.nlm.nih.gov/) database. Most SNPs are related to biological processes, immune responses, tuberculosis, or infectious diseases.

2.3 DNA Extraction

Peripheral blood (8 ml) from patients and healthy subjects was collected in EDTA-coated tubes. Genomic DNA from case and control groups was extracted from 200 uL peripheral whole blood samples using the Mini Spin Plus Extraction Kit (BioPur, Curitiba, Paraná, BR), according to the manufacturer’s instructions. The DNA samples were quantified by spectrophotometry at 260 nm using the Nanodrop 2000 device (NanoDrop Technologies, Wilmington, DE, United States). The purity of the analytes was evaluated through the ratio between absorbances obtained at the lengths of 260 and 280 nm, thus evaluating the quality of the DNA.

2.4 Single Nucleotide Polymorphism Genotyping

The polymorphisms were genotyped by allelic discrimination using TaqMan Open Array technology in the QuantStudio™12K Flex Real-Time PCR System (Thermo Fisher Scientific, Waltham, MA, United States), according to the manufacturer’s protocol. Data analysis was performed using the TaqMan® Genotyper Software package (Thermo Fisher Scientific, Waltham, MA, United States).

2.5 Ancestry-Informative Markers

A panel of 61 ancestry-informative markers was used to estimate the ancestral proportions of an Amazon population described previously by Santos et al. (2010) and expanded later by Ramos et al. (2016). Brazil is a country with a highly admixed population, composed mainly of Europeans, Africans, and Native Americans. We used this AIM panel that was composed of ancestry-specific markers that can estimate individual and population genetic contribution.

2.6 Statistical Analysis

Differences in baseline characteristics, including age, sex, and ancestry analysis, were compared using Fisher’s exact and Mann–Whitney tests. The associations between SNPs and TB were estimated by computing the odds ratios (ORs) and 95% confidence intervals (95% CIs) using logistic regression analyses, adjusted for sex and ancestry. ORs were defined concerning the case groups, i.e., ORs >1 represent an increased risk of TB. A p-value < 0.05 was considered statistically significant. Hardy–Weinberg equilibrium (HWE) proportion tests with the Bonferroni correction were used to evaluate the quality of the genotype data.

3 Results

There were 52 males and 126 females, with total of 178 healthy controls (mean age 70.82 ± 1.8 years; 52 males and 126 females) were enrolled. Both significant differences were found in the distribution of age and sex between cases and healthy controls. The population structure results showed significant differences in European, Amerindian, and African contributions in the cases compared to controls. As expected, the population ancestry showed a higher Amerindian and African contribution and a lower European ancestry in the opposite direction in TB patients than that in controls (Table 1).
TABLE 1

Clinical characteristics and genetic ancestry of subjects.

VariableCase (n = 190)Control (n = 176) p-value
Age (years)51.8 (49.2–54.4)70.82 (68.5–72.1)<0.001 a
Sex (male/female)88(46.3%)/102(53.7%)52(29.3%)/126(70.7%)0.001 b
EUR ancestry b 0.25 (0.23–0.27)0.45 (0.42–0.48)<0.001 c
AMR ancestry b 0.42 (0.38–0.43)0.31 (0.28–0.32)<0.001 c
AFR ancestry b 0.33 (0.31–0.35)0.24 (0.22–0.26)<0.001 c

Mann–Whitney test.

Fisher’s exact Test.

Multivariate regression logistic. Data are presented as median ±standard deviation.

Clinical characteristics and genetic ancestry of subjects. Mann–Whitney test. Fisher’s exact Test. Multivariate regression logistic. Data are presented as median ±standard deviation. A total of 26 SNPs were tested for the Hardy–Weinberg equilibrium with the Bonferroni correction (Table 2). In overall 26 SNPs, 10 markers were excluded for further analyses, and the remaining 16 SNPs were included for subsequent analysis by the Hardy–Weinberg equilibrium (Table 3). The results indicated that seven SNPs showed a significant association with TB risk, and those SNPs were rs10035440 in DROSHA, rs7372209 in miR26-a1, rs1834306 in miR100, rs4919510 in miR608, rs10739971 in pri-let-7a-1, rs3746444 in miR499, and rs6505162 in miR423 (Table 4).
TABLE 2

All 26 SNPs in microRNA and DROSHA genes with Hardy-Weinberg equilibrium (HWE) tests with the Bonferroni correction.

Gene p-value
DROSHA (rs639174)0.001
DROSHA (rs10035440)0.787*
miR453 (rs56103835)0.817*
miR 2053 (rs10505168)0.109*
miR300 (rs12894467)1*
miR-146A (rs2910164)0.861*
miR196A2 (rs11614913)1*
miR149 (rs2292832)<0.001
AGO01 (rs636832)0.850*
miR200B/200A/429 (rs9660710)<0.001
miR20b/miR-17-5P (rs3660)0.022
miR608 (rs4919510)0.125*
miR499 (rs3746444)0.204*
miR605 (rs2043556)0.003
miR570 (rs4143815)0.008
miR200C (rs12904)0.340*
pre-miR938 (rs2505901)<0.001
pri-let-7a-1 (rs10739971)0.113*
miR219A1 (rs107822)0.211*
miR604 (rs2368392)0.002
miR26-a1 (rs7372209)0.183*
miR100 (rs1834306)0.718*
miR219-1 (rs213210)<0.001
miR4513 (rs2168518)0.073*
miR423 (rs6505162)1*
DROSHA (rs3805500)<0.001
TABLE 3

Association analysis of 16 SNPS with risk of TB disease in accordance with the Hardy–Weinberg equilibrium.

Genotype (SNP ID)Case (%)Control (%) p-value OR (95% CI)
DROSHA (rs10035440) n = 107 n = 148<0.001*TT + CT vs. CC
CC35 (33%)06 (04%)15.58 (5.04-48.15)a
CT72 (67%)44 (30%)0.996TT vs. CT + CCb
TT0 (0%)98 (66%)
miR453 (rs56103835) n = 75 n = 1420.322TT + CT vs. CC
CC09 (12%)07 (05%)1.80 (0.56–5.77)a
CT33 (44%)54 (38%)0.142TT vs. CT + CC
TT33 (44%)81 (57%)1.60 (0.85-3.00)b
miR 2053 (rs10505168) n = 67 n = 1220.975TT + CT vs. CC
CC10 (15%)19 (15%)1.05 (0.39-2.58)a
CT29 (43%)47 (39%)0.931TT vs. CT + CC
TT28 (42%)56 (46%)1.03 (0.52–2.03)b
miR300 (rs12894467) n = 146 n = 1410.266TT + CT vs. CC
CC17 (11%)20 (14%)1.56 (0.71-3.44)a
CT80 (55%)46 (33%)0.654TT vs. CT + CC
TT49 (34%)75 (53%)1.12 (0.66–1.90)b
miR146A (rs2910164) n = 131 n = 1600.696GG + CG vs. CC
CC13 (10%)18 (11%)0.845 (0.36-1.96)a
CG59 (45%)74 (46%)0.590GG vs. CG + CC
GG59 (45%)68 (43%)1.15 (0.67–1.97)b
miR196A2 (rs11614913) n = 96 n = 1450.634TT + CT vs. CC
CC50 (52%)65 (45%)1.15 (0.64-2.07)a
CT41 (43%)65 (45%)0.239TT vs. CT + CC
TT05 (05%)15 (10%)1.98 (0.63–6.18)b
AGO01 (rs636832) n = 105 n = 1500.643GG + AG vs. AA
AA15 (14%)14 (09%)1.22 (0.51-2.90)a
AG45 (43%)67 (45%)0.450GG vs. AG + AA
GG45 (43%)69 (46%)0.80 (0.45–1.42)b
miR608 (rs4919510) n = 116 n = 161<0.001*GG + CG vs. CC
CC21 (18%)85 (53%)4.53 (2.30-8.92)a
CG46 (40%)58 (36%)<0.001*GG vs. CG + CC
GG49 (42%)18 (11%)4.13 (2.25-7.60)b
miR499 (rs3746444) n = 127 n = 1670.995GG + AG vs. AAa
AA0 (0%)126 (75%)
AG31 (25%)36 (22%)<0.001*GG vs. AG + AA
GG96 (75%)05 (3%)0.009 (0.003–0.26)b
miR200C (rs12904) n = 106 n = 1560.474GG + AG vs. AA
AA35 (33%)38 (24%)1.25 (0.67–2.33)a
AG42 (39%)72 (46%)0.717GG vs. AG + AA
GG29 (28%)46 (30%)1.12 (0.60-2.07)b
pri-let-7a-1 (rs10739971) n = 91 n = 83<0.001*GG + AG vs. AA
AA70 (76.92%)32 (38%)6.14 (2.88-13.08)a
AG17 (18.68%)33 (40%)<0.001*GG vs. AG + AA
GG4 (4.4%)18 (22%)7.25 (2.13-24.69)b
miR219-1(rs107822) n = 90 n = 1520.528TT + CT vs. CC
CC50 (55%)85 (56%)1.20 (0.67–2.17)a
CT33 (37%)53 (35%)0.994TT vs. CT + CC
TT7 (8%)14 (9%)0.99 (0.34-2.87)b
miR26-a1 (rs7372209) n = 113 n = 1450.752TT + CT vs. CC
CC49 (44%)70 (48%)0.91 (0.52-1.59)a
CT58 (51%)56 (39%)0.017*TT vs. CT + CC
TT6 (5%)19 (13%)3.75 (1.26–11.15)b
miR100 (rs1834306) n = 76 n = 1230.001*GG + AG vs. AA
AA35 (46%)33 (27%)3.39 (1.67–6.85)a
AG31 (41%)64 (52%)0.128GG vs. AG + AA
GG10 (13%)26 (21%)1.99 (0.81-4.86)b
miR4513 (rs2168518) n = 125 n = 1630.505GG + AG vs. AA
AA9 (7%)22 (13%)0.73 (0.29–1.82)a
AG51 (41)61 (38%)0.931GG vs. AG + AA
GG65 (52%)80 (49%)1.02 (0.60-1.73)b
miR423 (rs6505162) n = 77 n = 1240.021*CC + AC vs. AA
AA8 (10%)30 (24%)0.33 (0.13–0.84)a
AC52 (68%)62 (50%)0.449CC vs. AC + AA
CC17 (22%)32 (26%)1.34 (0.62-2.90)b

p-values for logistic analyses of alternative models (dominant a and recessive b models) are shown. Multivariate logistic regression with sex and ancestry is used as covariates.

TABLE 4

Association analysis of seven significant SNPs with the risk of TB disease.

Genotype (SNP ID)Case (%)Control (%) p-value OR (95% CI)
DROSHA (rs10035440) n = 107 n = 148<0.001*TT + CT vs. CC
CC35 (33%)06 (04%)15.58 (5.04-48.15)a
CT72 (67%)44 (30%)0.996TT vs. CT + CC b
TT0 (0%)98 (66%)
miR608 (rs4919510) n = 116 n = 161<0.001*GG + CG vs. CC
CC21 (18%)85 (53%)4.53 (2.30-8.92)a
CG46 (40%)58 (36%)<0.001*GG vs. CG + CC
GG49 (42%)18 (11%)4.13 (2.25-7.60)b
miR499 (rs3746444) n = 127 n = 1670.995GG + AG vs. AAa
AA0 (0%)126 (75%)
AG31 (25%)36 (22%)<0.001*GG vs. AG + AA
GG96 (75%)05 (3%)0.009 (0.003–0.26)b
pri-let-7a-1 (rs10739971) n = 91 n = 83<0.001*GG + AG vs. AA
AA70 (76.92%)32 (38%)6.14 (2.88-13.08)a
AG17 (18.68%)33 (40%)<0.001*GG vs. AG + AA
GG4 (4.4%)18 (22%)7.25 (2.13-24.69)b
miR26-a1 (rs7372209) n = 113 n = 1450.752TT + CT vs. CC
CC49 (44%)70 (48%)0.91 (0.52-1.59)a
CT58 (51%)56 (39%)0.017*TT vs. CT + CC
TT6 (5%)19 (13%)3.75 (1.26–11.15)b
miR100 (rs1834306) n = 76 n = 1230.001*GG + AG vs. AA
AA35 (46%)33 (27%)3.39 (1.67–6.85)a
AG31 (41%)64 (52%)0.128GG vs. AG + AA
GG10 (13%)26 (21%)1.99 (0.81-4.86)b
miR423 (rs6505162) n = 77 n = 1240.021*CC + AC vs. AA
AA8 (10%)30 (24%)0.33 (0.13–0.84)a
AC52 (68%)62 (50%)0.449CC vs. AC + AA
CC17 (22%)32 (26%)1.34 (0.62-2.90)b

p-values for logistic analyses of alternative models (dominant a and recessive b models) are shown. Multivariate logistic regression with sex and ancestry is used as covariates. Genotypic frequency distributions are in accordance with the Hardy–Weinberg equilibrium (HWE, p > 0.05).

All 26 SNPs in microRNA and DROSHA genes with Hardy-Weinberg equilibrium (HWE) tests with the Bonferroni correction. Association analysis of 16 SNPS with risk of TB disease in accordance with the Hardy–Weinberg equilibrium. p-values for logistic analyses of alternative models (dominant a and recessive b models) are shown. Multivariate logistic regression with sex and ancestry is used as covariates. Association analysis of seven significant SNPs with the risk of TB disease. p-values for logistic analyses of alternative models (dominant a and recessive b models) are shown. Multivariate logistic regression with sex and ancestry is used as covariates. Genotypic frequency distributions are in accordance with the Hardy–Weinberg equilibrium (HWE, p > 0.05). The results of the genotype distribution showed that the SNPs rs10035440 (DROSHA) and rs1834306 (miR100) were associated with an increased risk of TB (OR = 15.58, 95% CI [5.04-48.15] and OR = 3.39, 95% CI [1.67–6.85], respectively) in the dominant model. The SNP rs7372209 (miR26-a1) was associated with an increased risk of TB in a recessive model (OR = 3.75, 95% CI [1.26–11.15]). In addition, the SNPs rs4919510 (miR608) and rs10739971 (pri-let-7a-1) were associated with an increased risk of TB in dominant and recessive models. The SNP rs4919510 was associated with an increased risk of TB in the analysis of the dominant model (OR = 4.53, 95% CI [2.30–8.92]) and in the analysis of the recessive model (OR = 4.13, 9 5% CI [2.25–7.60]). The SNP rs10739971 was associated with an increased risk of TB in the analysis of the dominant model (OR = 6.14, 95% CI [2.88–13.08]) and in the analysis of the recessive model (OR = 7.25, 95% CI [2.13–24.69]). However, the SNPs rs3746444 and rs6505162 were associated with a low risk of TB in the analysis of the recessive model (OR = 0.009, 95% CI [0.003–0.26]) and rs6505162, in the analysis of the dominant model (OR = 0.33, 95% CI [0.13–0,84]).

4 Discussion

In the present study, we examined the possible association of polymorphisms in miRNA and DROSHA genes with tuberculosis susceptibility in the Brazilian Amazonian population. There were 52 males and 126 females, with total of 178 healthy controls. According to our results, we found seven SNPs in different genes that were associated with TB susceptibility. However, there are relatively few reports regarding the association of genetic variants and susceptibility to tuberculosis in an admixture of population such as the Brazilian Amazonian population. Our previous study investigated the effect of ancestral background on TB susceptibility among the Brazilian Amazonian population. The results indicated that Amerindian (compared to African and European) ancestry populations were significantly associated as a risk factor for susceptibility to TB in the Brazilian Amazonian population (Leal et al., 2020). In the present study, we used ancestry-informative markers (AIMs) to estimate genetic ancestry and control for stratification to investigate genetic association among Brazilian admixed populations. Our results suggested that the SNPs rs10035440 (DROSHA), rs4919510 (miR608), rs10739971 (pri-let-7a-1), rs7372209 (miR26-a1), and rs1834306 (miR100) were associated to an increased risk of TB. With respect to SNPs rs3746444 (miR499) and rs6505162 (miR423), these genetic variants were associated to a decreased risk for TB susceptibility in active-TB patients. Previous studies have revealed that deregulation of miRNAs and miRNA-related genes occur in many diseases (de Souza et al., 2020; Silva et al., 2020). DROSHA initiates the biosynthesis of miRNAs by processing pri-miRNAs. Single nucleotide polymorphisms (SNPs) in miRNA biosynthesis genes, DROSHA, were indicated to be correlated with cancer risk as pediatric ALL (Gutierrez-Camino et al., 2014; López-López et al., 2014). Some studies suggested that genetic variations were associated with cancer, HBV infection, and sepsis. Dai et al. (2018) reported that the rs4919510 polymorphism in miRNA-608 was associated with a decreased risk of collateral cancer (Dai et al., 2018). López-López et al. (2014) indicated significant associations between rs4919510 polymorphism in miRNA-608 and toxicity for cancer treatment (López-López et al., 2014). Al-Qahtani et al. (2017) found that miR-608 rs4919510 was associated with an increased risk of disease progression in patients with HBV (Al-Qahtani et al., 2017). Zhang et al. (2015) indicated that miR-608 rs4919510 was found to be strongly associated with a higher risk of developing sepsis and multiple organ dysfunction (Zhang et al., 2015). miRNA let-7 is involved in numerous cellular processes, inflammation, immunity, protective functions, and viral infections (Bernstein et al., 2021). Li et al. (2016) reported the relationship of the pri-let-7a-1 rs10739971 polymorphism with the prognosis of gastric cancer patients in northern China (Li et al., 2016). M. tuberculosis suppresses the innate immune response in macrophages, when suppressing miRNA let-7f expression, and modulates the immune response to TB infection by elevating target expression, A20, an inhibitor of the NF-κB pathway (Kumar et al., 2015). Ni et al. (2014) and Kleinsteuber et al. (2013) reported that M. tuberculosis can modulate the expression of host miRNA and limit the response of macrophages during TB infection. miRNA 26-A targets a component (P300) of the IFN-y signaling cascade and was found to be differently expressed during tuberculosis infection (Kleinsteuber et al., 2013; Ni et al., 2014). miRNA-26a regulates innate immune signaling, macrophages polarization, and trafficking of Mycobacterium tuberculosis to lysosomes during TB infection (Sahu et al., 2017). It also plays a role in intestinal inflammation (Zhang et al., 2021), preeclampsia (Eskandari et al., 2019), and cancer (Ying et al., 2016). Studies have shown that miRNA-100 is associated with the adaptive immune system (Negi et al., 2015), anti-inflammatory function in the vascular system (Pankratz et al., 2018), and the occurrence, development, and cancer invasion (Liu et al., 2012; Huang et al., 2020). Genetic variation in miRNA-100 rs1834306 was found to be an increased risk of gastrointestinal disease (Zhu et al., 2020), increased risk of Hepatitis B virus (Motawi et al., 2019, 1834306), and a decreased risk for esophageal squamous cell carcinoma (Zhu et al., 2015) in several studies. Li et al. (2011) reported that there was no association between miR-499 rs3746444 and pulmonary tuberculosis (PTB) risk in the Han population; however, subjects carrying the C allele showed a decreased PTB risk. Li et al. also found that there was an association between rs3746444 and PTB in the Tibetan population, and individuals carrying the C allele exhibited an increased PTB risk (Li et al., 2011). Naderi et al. (2015) indicated a lack of association between miRNA-146a rs2910164 and miRNA-499 rs3746444 gene polymorphisms and susceptibility to pulmonary tuberculosis (Naderi et al., 2015). Additionally, miR-499 rs3746444 was related to other diseases, including acute lymphoblastic leukemia (de Souza et al., 2020), asthma (Dong et al., 2020, 49), and inflammatory arthritis (Wang and Pan 2019). Studies have evaluated the association between the SNP miRNA-423 rs6505162 and susceptibility to colorectal carcinoma (Jia et al., 2018) and coronary artery disease (Jha et al., 2019). A recent study showed that the expression of miRNA-423 was significantly increased in the serum of patients with tuberculosis, and the upregulation of miR-423-5p could suppress autophagosome–lysosome fusion in macrophages by posttranscriptional regulation of VPS33A (Tu et al., 2019).

5 Conclusion

In this study, it was possible to determine the genotypic frequencies for the SNP in selected genes as well as associations related to risk or protection for tuberculosis infection. We found seven genetic variants significantly associated in individuals with tuberculosis from the Amazon region. Our study revealed that the SNPs rs10035440 (DROSHA), rs7372209 (miR26-a1), rs1834306 (miR100), rs4919510 (miR608), and rs10739971 (pri-let-7a-1) were significantly associated with a high risk of TB. In addition, the SNPs rs3746444 (miR499) and rs6505162 (miR423) were significantly associated with a low risk of developing tuberculosis. Our study contributes to a better understanding of TB pathogenesis and may promote the development of new diagnostic tools against M. tuberculosis infection. Future studies must be carried out to evaluate the functional effects of polymorphisms of the selected genes as well as the inclusion of other SNPs and large sample study, to corroborate the findings for tuberculosis in our country.
  39 in total

1.  Genetic study of two single nucleotide polymorphisms within corresponding microRNAs and susceptibility to tuberculosis in a Chinese Tibetan and Han population.

Authors:  Dongdong Li; Dingdong Li; Tingting Wang; Xingbo Song; MeiLang Qucuo; Bin Yang; Junlong Zhang; Jun Wang; Binwu Ying; Chuanmin Tao; Lanlan Wang
Journal:  Hum Immunol       Date:  2011-04-12       Impact factor: 2.850

2.  miR-100 rs1834306 A>G Increases the Risk of Hirschsprung Disease in Southern Chinese Children.

Authors:  Yun Zhu; Ao Lin; Yi Zheng; Xiaoli Xie; Qiuming He; Wei Zhong
Journal:  Pharmgenomics Pers Med       Date:  2020-08-10

3.  miR-26a attenuates colitis and colitis-associated cancer by targeting the multiple intestinal inflammatory pathways.

Authors:  Wei Zhang; Xianghui Fu; Jiansheng Xie; Hongming Pan; Weidong Han; Wendong Huang
Journal:  Mol Ther Nucleic Acids       Date:  2021-03-01       Impact factor: 8.886

4.  MicroRNA 26a (miR-26a)/KLF4 and CREB-C/EBPβ regulate innate immune signaling, the polarization of macrophages and the trafficking of Mycobacterium tuberculosis to lysosomes during infection.

Authors:  Sanjaya Kumar Sahu; Manish Kumar; Sohini Chakraborty; Srijon Kaushik Banerjee; Ranjeet Kumar; Pushpa Gupta; Kuladip Jana; Umesh D Gupta; Zhumur Ghosh; Manikuntala Kundu; Joyoti Basu
Journal:  PLoS Pathog       Date:  2017-05-30       Impact factor: 6.823

Review 5.  miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy.

Authors:  Naveed Sabir; Tariq Hussain; Syed Zahid Ali Shah; Antonio Peramo; Deming Zhao; Xiangmei Zhou
Journal:  Front Microbiol       Date:  2018-03-29       Impact factor: 5.640

6.  MicroRNA-100 functions as a tumor suppressor in cervical cancer via downregulating the SATB1 expression and regulating AKT/mTOR signaling pathway and epithelial-to-mesenchymal transition.

Authors:  Cuiping Huang; Xiaobo Qin; Na Zhao; Huijing Jin; Shuangjun Zhang; Haiyan Yang
Journal:  Oncol Lett       Date:  2020-05-29       Impact factor: 2.967

7.  Differential Targeting of c-Maf, Bach-1, and Elmo-1 by microRNA-143 and microRNA-365 Promotes the Intracellular Growth of Mycobacterium tuberculosis in Alternatively IL-4/IL-13 Activated Macrophages.

Authors:  Ousman Tamgue; Lorna Gcanga; Mumin Ozturk; Lauren Whitehead; Shandre Pillay; Raygaana Jacobs; Sugata Roy; Sebastian Schmeier; Malika Davids; Yulia A Medvedeva; Keertan Dheda; Harukazu Suzuki; Frank Brombacher; Reto Guler
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

8.  Association of rs2910164 Polymorphism in miRNA-146 and rs3746444 Polymorphism in miRNA-499 with Inflammatory Arthritis: A Meta-Analysis.

Authors:  Dingjian Wang; Guixia Pan
Journal:  Biomed Res Int       Date:  2019-05-16       Impact factor: 3.411

9.  Association of microRNA-423 rs6505162 C>A polymorphism with susceptibility and metastasis of colorectal carcinoma.

Authors:  Wenrui Jia; Liuyan Zeng; Shengqun Luo; Fei Bai; Rui Zhong; Lin Wu; Guo-Liang Huang; Xingxiang Pu
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

10.  The role of microRNA-608 polymorphism on the susceptibility and survival of cancer: a meta-analysis.

Authors:  Zhi-Ming Dai; Jian-Rui Lv; Kang Liu; Xiao-Ming Lei; Wei Li; Gang Wu; Xing-Han Liu; Yu-Xiao Zhu; Qian Hao; Zhi-Jun Dai
Journal:  Aging (Albany NY)       Date:  2018-06-16       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.